Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

SK Bio's 2020 Plans Undeterred By Pandemic

US Launch, IPO Moving Ahead

Jun 17 2020

• By Jung Won Shin

Jeong Woo Cho — SK Bio CEO Jeong Woo Cho Outlines Plans • Source: SK Biopharmaceuticals

Related Content

Major Milestone For SK Biopharm As Anti-Epileptic Gets US Approval

Nov 25 2019

Interview: Arvelle Aims To Be Major Player In CNS

Apr 01 2020

SK Biopharm’s Hefty IPO To Support Novel Anti-Epileptic, Pipeline

Jun 02 2020

Related Companies

SK Biopharmaceuticals Co., Ltd

Arvelle Therapeutics GmbH

Additional Topics

South Korea Asia Pacific Business Strategies Commercial Neurology BioPharmaceutical

More from South Korea

More from Focus On Asia

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.